The blog
Clinical trial results, TGA regulatory progress and research updates on retatrutide and the wider peptide space — explained for Australians.
29 September 2026 · bpc-157 · peptides · research · regulation · australia
A 2025 journal exchange put a number on BPC-157 research: one group is linked to over 80% of it. What that means, and is BPC-157 legal in Australia?
Read more →27 September 2026 · bpc-157 · tb-500 · research · australia · tendon
A 2026 rat study tested BPC-157, TB-500 and the combo on Achilles repair. The stack beat neither alone. What that means for BPC-157 research and Australia.
Read more →24 September 2026 · bpc-157 · peptides · pharmacokinetics · tga · research
BPC-157 survives stomach acid — but no study has measured plasma levels after a swallowed dose. What the PK data shows, and why AU law ignores the route.
Read more →21 September 2026 · bpc-157 · peptides · research · regulation
Is BPC-157 legal in Australia, and where does it actually come from? A 2026 investigation found its parent protein's sequence has never been published.
Read more →18 September 2026 · bpc-157 · peptides · pharmacokinetics · tga · research
BPC-157 research has animal pharmacokinetics and no validated human dose. What a 2026 formulation review found, plus BPC-157's legal status in Australia.
Read more →16 September 2026 · bpc-157 · peptides · research · regulation · australia
Is oral BPC-157 absorbed? The "stable in gastric juice" claim is a test-tube result, not human data — plus BPC-157 research, PK gaps and Australian law.
Read more →13 September 2026 · bpc-157 · peptide research · tga · clinical trials
BPC-157 research did reach human trials once - a Pliva ulcerative colitis study never published in a journal. What that means, plus its legal status in Australia.
Read more →10 September 2026 · bpc-157 · peptides · research · australia · regulation
BPC-157 clears the blood in under 30 minutes but is credited with effects lasting days. What the PK data, a 2026 review and Australia's TGA rules say.
Read more →27 August 2026 · bpc-157 · peptides · healing · tga
BPC-157 is hugely popular but barely tested in humans. What the animal studies show, why the TGA made it prescription-only, and where WADA and the FDA stand.
Read more →Stay informed
Retatrutide is not yet available to the public. But when it is, you will want to be first to know. Sign up to receive:
Get the free guide + updates
Enter your details once on our free access guide page — instant download, plus we'll email you the moment there's real news.